KR102642703B1 - Cartridge removable nicotine inhaler - Google Patents

Abstract

The inhaler according to one embodiment includes a body including a first end face, a second end face opposite the first end face, and a side face between the first end face and the second end face, and A cartridge insertable into the interior of the main body through a second end surface and containing a first material, a spray portion formed on the first end surface of the main body and spraying the first material to the outside of the main body, and the sprayer. It may include a tube extending from the four parts to the second end surface of the main body, and the cartridge may include a first cartridge area and a second cartridge area separated from each other by a partition formed therein, and the first cartridge area may include a second cartridge area separated from each other by a partition formed therein. The first material may be provided in either the cartridge area or the second cartridge area, and the first cartridge area and the second cartridge area may communicate when the cartridge is inserted into the interior of the main body. .

Description

CARTRIDGE REMOVABLE NICOTINE INHALER}

Various embodiments below relate to inhalers. For example, various embodiments below relate to cartridge removable inhalers.

Various means have been developed for inhaling tobacco substances, such as nicotine. For example, there are cigarette-type cigarettes. Cigarette-type cigarettes are made by processing tobacco leaves into a cut paste, which is then made into a rod shape. Users can inhale nicotine by directly lighting and burning the sheath of a cigarette-type cigarette.

There are also, for example, heated cigarettes that do not burn. These can be implemented in several ways. For example, a liquid nicotine solution can be heated and inhaled in vapor form.

There are also inhalers, for example. Inhaler can allow the user to inhale nicotine powder or a medium in which nicotine is dissolved. Inhalers may not heat inhalants containing tobacco substances.

For example, Korean Publication No. 2007-0020830 discloses a nicotine inhalation device in the form of a cigarette case.

The above-mentioned background technology is possessed or acquired by the inventor in the process of deriving the present invention, and cannot necessarily be said to be known technology disclosed to the general public before the application for the present invention.

The object according to one embodiment is to provide an inhaler that allows nicotine to be inhaled without heating the nicotine medium.

An object according to one embodiment is to provide an inhaler that can prevent disadvantages caused by a heating means, such as liquid condensation, leakage, and burning of the heating means.

The inhaler according to one embodiment includes a body including a first end face, a second end face opposite the first end face, and a side face between the first end face and the second end face, and A cartridge insertable into the interior of the main body through a second end surface and containing a first material, a spray portion formed on the first end surface of the main body and spraying the first material to the outside of the main body, and the sprayer. It may include a tube extending from the four parts to the second end surface of the main body, and the cartridge may include a first cartridge area and a second cartridge area separated from each other by a partition formed therein, and the first cartridge area may include a second cartridge area separated from each other by a partition formed therein. The first material may be provided in either the cartridge area or the second cartridge area, and the first cartridge area and the second cartridge area may communicate when the cartridge is inserted into the interior of the main body. .

The first cartridge region may be disposed closer to the first end surface than the second cartridge region.

The cartridge may be inserted into the body with the partition wall parallel to the first end face or the second end face.

The tube has a length that extends beyond the partition when the cartridge is inserted into the main body, and the tube can penetrate the partition when the cartridge is inserted into the main body.

The first material may be accommodated in the first cartridge region, and a second material for dissolving the first material may be accommodated in the second cartridge region.

The first substance may include a tobacco-related substance,

The second material may be a liquid medium.

The tobacco-related substance may be nicotine powder.

The tube has a length extending beyond the partition when the cartridge is inserted into the body, and the tube can be submerged in the second material when the cartridge is inserted into the body.

The first material may be produced by freeze-drying.

It may further include a suction portion formed around the spray portion on the first end surface of the main body.

It may further include a spring formed by being wound around the cartridge inserted into the main body.

The injection unit includes a buffer chamber formed inside the injection unit and in communication with the tube, a nozzle located on the opposite side of the tube on the injection unit, and a valve located across a portion of the buffer chamber between the tube and the nozzle. may include.

It may further include a control unit that controls opening or closing of the valve.

The inhaler according to one embodiment can allow nicotine to be inhaled without heating the nicotine medium.

The inhaler according to one embodiment can prevent disadvantages caused by the heating means, such as liquid condensation, leakage, and burning of the heating means.

The effects of the inhaler according to one embodiment are not limited to those mentioned above, and other effects not mentioned may be clearly understood by those skilled in the art from the description below.

Figure 1 is a perspective view of an inhaler according to an embodiment.
Figure 2 is a cross-sectional view of the inhaler according to one embodiment along the cross-section line AA of Figure 1.
FIG. 3 shows a state in which the second end surface of the inhaler according to one embodiment is opened in the cross-sectional view of FIG. 2.
Figure 4 is a perspective view of a cartridge of an inhaler according to one embodiment.
Figure 5 is a cross-sectional view of the cartridge of the inhaler according to one embodiment along the cross-section line BB of Figure 4.
FIG. 6 illustrates a first state in which a cartridge is inserted into an inhaler according to an embodiment along the cross-sectional line AA of FIG. 1 .
FIG. 7 shows a second state in which a cartridge is inserted into an inhaler according to an embodiment, along the cross-sectional line AA of FIG. 1.
FIG. 8 shows a third state in which a cartridge is inserted into an inhaler according to an embodiment, along the cross-sectional line AA of FIG. 1.
Figure 9 shows a state in which a solution of a tobacco-related substance moves to the spray unit along the tube of the inhaler according to one embodiment.
Figure 10 shows a state in which a solution of a tobacco-related substance is prepared in the buffer chamber of the injection unit of the inhaler according to an embodiment.
Figure 11 shows a state in which a solution of a tobacco-related substance is sprayed from the spray portion of an inhaler according to an embodiment.

Hereinafter, embodiments will be described in detail with reference to the attached drawings. However, since various changes can be made to the embodiments, the scope of the patent application is not limited or limited by these embodiments. It should be understood that all changes, equivalents, or substitutes for the embodiments are included in the scope of rights.

The terms used in the examples are for descriptive purposes only and should not be construed as limiting. Singular expressions include plural expressions unless the context clearly dictates otherwise. In this specification, terms such as “comprise” or “have” are intended to designate the presence of features, numbers, steps, operations, components, parts, or combinations thereof described in the specification, but are not intended to indicate the presence of one or more other features. It should be understood that this does not exclude in advance the possibility of the existence or addition of elements, numbers, steps, operations, components, parts, or combinations thereof.

Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by a person of ordinary skill in the technical field to which the embodiments belong. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and unless explicitly defined in the present application, should not be interpreted in an ideal or excessively formal sense. No.

In addition, when describing with reference to the accompanying drawings, identical components will be assigned the same reference numerals regardless of the reference numerals, and overlapping descriptions thereof will be omitted. In describing the embodiments, if it is determined that detailed descriptions of related known technologies may unnecessarily obscure the gist of the embodiments, the detailed descriptions are omitted.

Additionally, in describing the components of the embodiment, terms such as first, second, A, B, (a), and (b) may be used. These terms are only used to distinguish the component from other components, and the nature, sequence, or order of the component is not limited by the term. When a component is described as being "connected," "coupled," or "connected" to another component, that component may be directly connected or connected to that other component, but there is no need for another component between each component. It should be understood that may be “connected,” “combined,” or “connected.”

Components included in one embodiment and components including common functions will be described using the same names in other embodiments. Unless stated to the contrary, the description given in one embodiment may be applied to other embodiments, and detailed description will be omitted to the extent of overlap.

FIG. 1 is a perspective view of the inhaler 100 according to an embodiment, and FIG. 2 is a cross-sectional view of the inhaler 100 according to an embodiment along the cross-sectional line A-A of FIG. 1.

The inhaler 100 according to one embodiment includes a main body 110, an injection portion 140 that may be formed on the first end surface 113 of the main body 110, and a first end surface 113 of the main body 110. ) side, a suction part 130 that can be formed around the injection part 140, a tube 150 extending from the injection part 140 toward the second end surface 114 of the main body 110, and a main body ( It may include a spring 160 accommodated inside 110).

The main body 110 may include a housing 111 that constitutes the external appearance of the main body 110 and can be held by a user, and a receiving space 112 that is a space inside the housing 111.

The shape of the housing 111 may vary. For example, the housing 111 may be cylindrical or prismatic.

The receiving space 112 may accommodate the spring 160 as mentioned above, and may also accommodate at least a portion of the tube 150 extending from the injection unit 140 to the second end surface 114.

In addition, as mentioned above, the main body 110 has a first end surface 113 located close to the user's mouth when the user uses the inhaler 100 according to an embodiment, a second end surface 114 on the opposite side, and It may include a side surface 115 between the first end surface 113 and the second end surface 114.

The injection unit 140 may communicate with the tube 150 and includes a buffer chamber 141 formed inside the injection unit 140, a nozzle 142 located on the opposite side of the tube 150 on the injection unit, and a buffer chamber. It may include a valve 143 positioned across 141.

As will be described later, the buffer chamber 141 may be a space where a first material solution (eg, the first material solution M3 in FIG. 10) can reside.

The valve 143 may be positioned across a portion of the buffer chamber 141 between the tube 150 and the nozzle 142 at any position. The valve 143 may determine whether the first material solution M3 is to be injected to the outside of the inhaler 100.

The nozzle 142 may be an outlet through which the first material solution is directly sprayed. The shape of the nozzle 142 may vary. For example, it may be in the form of a baffle or a complex structure of a venturi and a baffle so that the sprayed solution can be split by impact.

The suction part 130 may be a part that directly contacts the oral cavity of the user using the inhaler 100. In contrast, the inhaler 100 according to one embodiment may not include the suction part 130, and in this case, the spray part 140 may directly contact the user's oral cavity. Hereinafter, an embodiment in which the suction unit 130 is present will be intensively described.

The suction unit 130 may protrude further than the injection unit 140 in the longitudinal direction of the inhaler 100 according to one embodiment. Additionally, the diameter of the external shape of the suction unit 130 may be larger than the diameter of the external shape of the injection unit 140. Additionally, the suction unit 130 may be formed around the injection unit 140.

The tube 150 may communicate with the receiving space. The extension length of the main body 110 of the tube 150 toward the second end surface 114 may be determined in relationship with a cartridge (eg, cartridge 120 in FIG. 4) to be described later. Additionally, the end of the tube 150 on the second end surface 114 may be sharp.

The spring 160 may be formed by being wound within the receiving space 112.

Meanwhile, the inhaler 100 according to one embodiment may further include a control unit (not shown). The control unit may be located outside or inside the housing 111, or at any location in the main body 110. The controller may control the opening or closing of the valve 143. The control unit detects that the user's oral cavity comes into contact with the suction unit 130, detects the pressure with which the user inhales, or detects the user's operation of the switch formed on the main body 110 or the suction unit 130. The valve 143 can be controlled through the like.

The control unit may include sensors (not shown) or switches (not shown) necessary to perform the above-mentioned sensing operations.

FIG. 3 illustrates a state in which the second end surface 114 of the inhaler 100 according to an embodiment is opened in the cross-sectional view of FIG. 2 .

The second end surface 114 of the inhaler 100 according to one embodiment may be selectively open. A detachable lid (not shown) or a hinged lid (not shown) may be formed on the second end surface 114. The manner in which the second end surface 114 of the body 110 is opened is not limited to the above description and may vary.

As will be described later, a cartridge (eg, cartridge 120 of FIG. 4) can be inserted through the open second end surface 114.

FIG. 4 is a perspective view of the cartridge 120 of the inhaler 100 according to an embodiment, and FIG. 5 is a cross-sectional view of the cartridge 120 of the inhaler 100 according to an embodiment along the cross-section line B-B of FIG. 4. am.

The inhaler 100 according to one embodiment may further include a cartridge 120 containing the first material (M1). Meanwhile, in the present specification, the inhaler 100 may be used simultaneously in two senses: a device including the cartridge 120 or a device not including the cartridge 120.

Referring to Figure 5, a cross section of the cartridge 120 appears. The cartridge 120 may include a first cartridge area 121 and a second cartridge area 122 separated by a partition 123 formed therein.

The partition wall 123 may divide the space inside the cartridge 120 into a first cartridge area 121 and a second cartridge area 122. The shape of the partition wall 123 in FIG. 5 may vary. For example, the partition wall 123 may be composed of a thin film or a layer.

The partition wall 123 may divide the internal space of the cartridge 120 in various orientations within the cartridge 120. For example, the partition wall 123 may be formed perpendicular to the longitudinal direction of the cartridge 120, may be formed parallel to the longitudinal direction of the cartridge 120, or may be formed at an arbitrary angle.

Meanwhile, the distinction between the first cartridge area 121 and the second cartridge area 122 may not be absolute. For example, when the cartridge 120 is inserted into the receiving space (e.g., the receiving space 112 of FIG. 2) of the main body (e.g., the main body 110 of FIG. 2), the first end surface (e.g., FIG. 2) A portion located close to the first end surface 113 may be designated as the first cartridge area 121.

Meanwhile, the cartridge 120 may be inserted into the main body 110 with the partition wall 123 parallel to the first end surface or the second end surface.

A first material (M1) is accommodated in one of the first cartridge area 121 and the second cartridge area 122, and a second material (M2) capable of dissolving the first material (M1) is contained in the other. It can be accepted.

The second material (M2) may be a liquid medium in which the first material (M1) can be dissolved. For example, the second material (M2) may be a mixture containing water, a preservative, a flavor component, etc. For example, the second material (M2) may be composed of 60 to 80% moisture and may include excipients such as preservatives and flavor ingredients. Flavor ingredients may include ingredients that can provide various flavors or flavors to the user.

Additionally, the first material (M1) may include a material obtained by processing tobacco leaves. For example, it may include cut paste obtained by processing tobacco leaves. Alternatively, the first material (M1) may be a material containing nicotine, nicotine salt, nicotine alkaloid, nicotine derivatives, etc. For example, the first material (M1) may be nicotine powder.

Alternatively, the first material (M1) may include a non-tobacco material. For example, the first substance (M1) may include caffeine, vitamins, flavoring agents, etc. Additionally, the first material M1 may include functional materials other than the materials mentioned above.

Additionally, the first material (M1) may be manufactured using a freeze-drying method. In this case, when the first material (M1) is mixed with the second material (M2), it can be dissolved in the second material (M2) within a few minutes.

FIG. 6 shows a first state in which the cartridge 120 is inserted into the inhaler 100 according to an embodiment along the cross-sectional line A-A of FIG. 1, and FIG. 7 shows a first state in which the cartridge 120 is inserted into the inhaler 100 according to an embodiment. The second state in which the cartridge 120 is inserted is shown along the cross-sectional line A-A in FIG. 1, and FIG. 8 shows the third state in which the cartridge 120 is inserted into the inhaler 100 according to an embodiment of FIG. 1. It is drawn along the cross-sectional line A-A.

Hereinafter, with reference to FIGS. 6 to 8 , a process in which the cartridge 120 is inserted into the receiving space 112 of the main body 110 and the first material solution M3 is prepared will be described.

Referring to FIG. 6, as described above, the second end surface 114 of the inhaler 100 according to one embodiment may be open, and the cartridge 120 may be exposed through the opened second end surface 114. may be inserted and enter the receiving space 112.

Referring to FIG. 7 , a state in which the partition wall 123 is broken and the first cartridge area 121 and the second cartridge area 122 are in communication is shown. The partition wall 123 of the cartridge 120 of the inhaler 100 according to one embodiment may be broken when the cartridge 120 is inserted into the main body 110, and the first cartridge area 121 and the second cartridge Areas 122 may be in communication.

For example, the partition wall 123 may be broken by the tube 150. Or, for example, it may be shredded through a shredding means (not shown) provided in the receiving space 112. Or, for example, it may be inserted after being previously shredded by another shredding tool (not shown) or by a user before being inserted into the receiving space 112.

When crushed by the tube 150, the tube 150 penetrates the outer wall of the cartridge 120 on the first cartridge area 121 and then penetrates the partition wall 123 to enter the second cartridge area 122. do.

After the partition wall 123 is broken, the first material (M1) that can be accommodated in the first cartridge area 121 may enter the second cartridge area 122 through the pierced portion of the partition wall 123. .

Meanwhile, the extended length of the tube 150 may be set to a length sufficient to penetrate the partition wall 123 of the cartridge 120. For example, the tube 150 may have a length that extends beyond the partition wall 123 when the cartridge 120 is inserted into the body 110. Also, for example, the tube 150 may be immersed in the second material M2 when the cartridge 120 is inserted into the main body 110.

Referring to Figure 8, cartridge 120 is shown fully inserted into receiving space 112. When the partition 123 begins to penetrate, the first material (M1) can enter the second cartridge area 122 as described above, and the second material (M2) that can be accommodated in the second cartridge area 122 ) can be dissolved in The first material M1 may be dissolved in the second material M2 to form a first material solution M3. Figure 8 shows the first material solution (M3) formed by gradual dissolution.

FIG. 9 shows a state in which the first material solution M3 moves to the injection unit 140 along the tube 150 of the inhaler 100 according to an embodiment, and FIG. 10 shows an inhaler according to an embodiment. A first material solution (M3) is prepared in the buffer chamber 141 of the spray unit 140 of the inhaler 100, and FIG. 11 shows the spray unit 140 of the inhaler 100 according to an embodiment. shows a state in which the first material solution (M3) is sprayed.

Hereinafter, with reference to FIGS. 9 to 11, the process of spraying the first material solution M3 to the outside of the inhaler 100 will be described.

Referring to FIG. 9 , the first material solution M3 formed in the second cartridge area 122 may move toward the buffer chamber 141 through the tube 150.

Various methods can be used to transport the first material solution (M3). For example, the spring 160 formed by winding the inside of the receiving space 112 may wind the outside of the cartridge 120 that can be inserted into the receiving space 112, and at this time, the force of the spring 160 The first material solution (M3) in the cartridge 120 can be transferred using . This will be explained in more detail below.

In addition, although not shown, the first material solution M3 may be transferred by creating pressure inside the cartridge 120 using compressed gas.

Meanwhile, the length of the tube 150 may be determined to be suitable for transferring the first material solution M3 inside the cartridge 120 to the buffer chamber 141. For example, the tube 150 may be sized to penetrate a central portion of the second cartridge section 122, and the tube 150 may also be lengthed close to the end of the second cartridge section 122. can be specified.

Referring to FIG. 10, the first material solution M3 transferred from the second cartridge area 122 to the buffer chamber 141 through the tube 150 may fill the buffer chamber 141. If the valve 143 is not opened, the first material solution M3 cannot be sprayed to the outside.

Referring to FIG. 11 , it is shown that the valve 143 is opened and the first material solution M3 filling the buffer chamber 141 is injected to the outside of the injection unit 140 through the nozzle 142. As described above, the injection solution V1 may be sprayed while the first material solution M3 is split by the nozzle 142.

For example, referring to FIGS. 9 to 11, when the tube 150 is inserted into the cartridge 120, some of the first material solution M3 may flow into the tube 150 due to capillary action (e.g., state in Figure 9). At this time, the spring 160 outside the cartridge may be maintained in a compressed state. Subsequently, when the compressed state of the spring 160 is released, the spring 160 expands, and the spring 160 pushes the section A of the upper structure that is in contact up in the direction of the injection unit 140 (e.g. state in Figure 10). The first material solution M3 may be pulled into the buffer chamber 141 while the section A of the upper structure acts as a dropper. Next, the valve 143 may be opened and the first material solution M3 may be injected through the nozzle 142 (e.g., the state of FIG. 11). Afterwards, the spring 160 can be compressed again to relieve the pressure in the section A of the upper structure, and the compression of the spring 160 changes the length of the spring 160 through push or rotation. This can be done through.

Although the embodiments have been described with limited drawings as described above, those skilled in the art can apply various technical modifications and variations based on the above. For example, the described techniques are performed in a different order than the described method, and/or components of the described system, structure, device, circuit, etc. are combined or combined in a different form than the described method, or other components are used. Alternatively, appropriate results may be achieved even if substituted or substituted by an equivalent.

Therefore, other implementations, other embodiments and equivalents of the claims also fall within the scope of the following claims.

100: Inhaler
110: main body
120: cartridge
130: suction part
140: injection unit
150: tube
160: spring

Claims (13)

a body comprising a first end face, a second end face opposite the first end face, and a side face between the first and second end faces;
a cartridge insertable into the interior of the body through the second end face of the body and including a first material;
a spray portion formed on the first end surface of the main body and spraying the first material to the outside of the main body; and
a tube extending from the spray unit to the second end surface of the main body;
Including,
The cartridge includes a first cartridge area and a second cartridge area separated from each other by a partition formed therein,
The first material is provided in either the first cartridge area or the second cartridge area,
The first cartridge area and the second cartridge area communicate when the cartridge is inserted into the interior of the main body,
Inhaler.
According to paragraph 1,
The cartridge is inserted into the body with the partition wall parallel to the first end face or the second end face,
Inhaler.
According to paragraph 2,
the tube has a length extending beyond the partition when the cartridge is inserted into the body, and the tube penetrates the partition when the cartridge is inserted into the main body,
Inhaler.
According to paragraph 1,
wherein the first cartridge region is disposed closer to the first end surface than the second cartridge region,
Inhaler.
According to paragraph 4,
The first material is accommodated in the first cartridge area,
The second cartridge area accommodates a second material for dissolving the first material,
Inhaler.
According to clause 5,
The first substance includes a tobacco-related substance,
The second material is a liquid medium,
Inhaler.
According to clause 6,
The tobacco-related substance is nicotine powder,
Inhaler.
According to clause 5,
wherein the tube has a length extending beyond the septum when the cartridge is inserted into the body, and wherein the tube is contained in the second material when the cartridge is inserted into the body.
Inhaler.
According to clause 6,
The first material is produced by freeze-drying,
Inhaler.
According to paragraph 1,
a suction portion formed around the spray portion at the first end surface of the main body;
Containing more,
Inhaler.
According to paragraph 1,
a spring formed by being wound around the cartridge inserted into the main body;
Containing more,
Inhaler.
According to paragraph 1,
The injection unit,
a buffer chamber formed inside the injection unit and communicating with the tube;
a nozzle located on an opposite side of the tube on the spray unit; and
a valve positioned across a portion of the buffer chamber between the tube and the nozzle;
Including,
Inhaler.
According to clause 12,
a control unit that controls opening or closing of the valve;
Containing more,
Inhaler.

Images